AHA reiterates support for most-favored nation drug price rule’s withdrawal

Oct 11, 2021 - 12:56 PM
AHA-OIG-letter

The AHA today restated its strong support for the Centers for Medicare & Medicaid Services’ withdrawal of its Most Favored Nation Model proposed rule. In January, the AHA questioned the proposal’s legality and structure, while expressing deep concerns for the extent to which patients would be negatively impacted by the policy. 

Related News Articles

Headline
Research finds drug prices increased without adding new clinical benefits
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023.…
Headline
AHA responds to Medicare $2 Drug List Model request for information
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Perspective
Working to Enact Key Priorities in Year-end Legislation to Ensure Patient Access to Care
December’s holiday rush is in full swing on Capitol Hill as Congress returned to Washington this week facing a long list of to-dos and a short time to do them…
Headline
Coalition ad campaign highlights life-saving impact of hospital care 
The Coalition to Strengthen America's Healthcare Dec. 4 launched a new national, seven-figure digital, cable and broadcast advertising campaign that highlights…
Headline
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
The AHA and 22 other organizations Nov. 22 urged Congress to pass an end-of-year health care package that includes action on alternative payment models and a…
Headline
Coalition report finds integration can benefit rural hospitals, access to care 
New analysis conducted by Dobson | DaVanzo released Nov. 21 by the Coalition to Strengthen America's Healthcare found that integration can provide more…